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Cytochrome P450 enzymes, which catalyze oxygenation reactions of both exogenous
and endogenous chemicals, are membrane bound proteins that require interaction
with their redox partners in order to function. Those responsible for drug and foreign
compound metabolism are localized primarily in the endoplasmic reticulum of liver, lung,
intestine, and other tissues. More recently, the potential for P450 enzymes to exist as
supramolecular complexes has been shown by the demonstration of both homomeric
and heteromeric complexes. The P450 units in these complexes are heterogeneous
with respect to their distribution and function, and the interaction of different P450s can
influence P450-specific metabolism. The goal of this review is to examine the evidence
supporting the existence of physical complexes among P450 enzymes. Additionally,
the review examines the crystal lattices of different P450 enzymes derived from
X-ray diffraction data to make assumptions regarding possible quaternary structures
in membranes and in turn, to predict how the quaternary structures could influence
metabolism and explain the functional effects of specific P450–P450 interactions.
Keywords: P450 cytochrome, protein–protein interaction (PPI), crystal structure, drug metabolism, microsomes,
liver
INTRODUCTION
The mammalian cytochromes P450 (P450 or CYP) that are primarily housed in the endoplasmic
reticulum are versatile catalysts that metabolize 75–90% of marketed drugs (Guengerich, 2006;
Lynch and Price, 2007). These enzymes use a heme group, coordinated in one of the axial positions
with a critical thiolate residue, to catalyze a diverse set of reactions through the mixed-function
oxygenation of substrate carbons and heteroatoms (Guengerich, 2001). In addition to catalyzing a
variety of reactions, the mammalian P450s also recognize a wide range of exogenous substrates
due to a variety of closely related enzymes, representing three to four gene families, that have
differing but overlapping substrate specificities (Nelson, 2006). Humans contain 57 P450 genes
expressed in a tissue-specific fashion (Zanger and Schwab, 2013), with approximately 13 P450s
being responsible for the majority of in vivo drug metabolism.
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The P450 catalytic cycle relies on molecular oxygen and
electrons supplied by the redox partners, cytochrome P450
reductase (CPR) and/or cytochrome b5. In this process, two
distinct electron-transfer steps occur (White and Coon, 1980),
each one following a protein-protein interaction with one of
the potential redox partners (Miwa et al., 1979). Thus, protein-
protein interactions are essential for optimal catalytic activities
of the P450s. In addition to the interactions with redox partners,
P450s also interact with each other. There is now considerable
evidence that these P450–P450 interactions influence P450-
mediated catalytic activities in form- and substrate-specific
manners. In fact, studies now demonstrate that the function
of a given P450 also can be altered by its own homomeric
interaction (Davydov et al., 2010; Reed et al., 2012). Our recent
review on this topic (Reed and Backes, 2016), in addition
to several other excellent reviews (Davydov, 2011; Reed and
Backes, 2012; Kandel and Lampe, 2014), have summarized the
studies that demonstrated the effects of specific P450–P450
interactions on enzyme function and have categorized the effects
mechanistically.
Although significant progress has been made to demonstrate
that the interaction of specific P450s can influence enzyme
function in membrane systems, very little is known about
the specific quaternary structures of the P450 complexes in
membranes and more importantly, into the ways in which
different types of physical interactions between P450s influence
function. Although many biophysical techniques have been
employed to detect multimeric P450 in membranes, these studies,
for the most part, are not conclusive with regards to specific
protein-protein interactions within the P450 complexes or to the
exact sizes of the multimeric complexes.
In contrast to the limits associated with the biophysical
techniques used to analyze membrane systems, X-ray crystal
structures provide clear images of protein conformation and
intermolecular arrangement. In addition, these structures clearly
elucidate the ways in which protein conformations change upon
the binding of different substrates. The crystallographic analysis
of human P450 forms has exploded this century. Numerous
structures of mammalian P450s with a variety of substrates have
been reported [reviewed in (Johnson and Stout, 2013)]. Because
of limitations related to determining both the specific sizes of
P450 complexes and the relative orientations of the P450 units
contained in these heteromeric complexes, detailed information
about the ways in which P450s may interact in vivo might
be inferred from X-ray crystal structures and crystallographic
lattices of the individual, purified forms. This approach was
used previously (Hazai et al., 2005); however, when the study
was published, there were only a limited number of available
structures of the mammalian P450s to analyze. Thus, in the
current review, the X-ray structures and the corresponding lattice
arrangements of human CYP1A2 (PDB: 2HI4); rabbit CYP2B4
(PDB: 1SUO and 1PO5); human CYP2C8 (PDB: 1PQ2); human
CYP2C9 (PDB: 1OG5); human CYP2C19 (PDB: 4GQS); human
CYP2D6 (PDB: 2F9Q);; human CYP3A4 (PDB: 2V0M, 2J0D,
1TQN, and 1W0F) have been interpreted with respect to the
reported effects of specific P450-P450 interactions on enzymatic
function.
Unlike our previous reviews that emphasized the functional
effects of P450–P450 interactions, this review will focus on the
physical studies that have been used to elucidate the nature of
P450 multimers and summarize the current state of knowledge
derived from these studies regarding the physical characteristics
of these oligomers. The crystal structures and crystallographic
arrays of different P450s will then be analyzed for their possible
relationships to protein–protein interactions in membranes and
to the possible ways that these interactions may explain some of
the functional effects associated with these interactions. Initially,
we will discuss instances of homomeric P450–P450 interactions
in membrane systems that appear to correspond very nicely
with available crystal structures of these P450s. Various types
of homomeric interactions identified in the crystal structures
will then be used to propose explanations for the functional
effects that are associated with specific heteromeric P450–P450
interactions. The possible role of protein conformational changes
in the functional effects of P450–P450 interactions will also be
addressed. Hopefully, the comparison of crystal structures will
provide a framework for future studies to determine whether
these functional effects can indeed be attributable to the 450–
P450 interactions deduced from the crystallographic analyses.
PHYSICAL STUDIES OF MEMBRANE
SYSTEMS CONTAINING P450s
Determination of P450–P450 Binding
Affinities
Purified P450s have a remarkable tendency to aggregate in
aqueous solutions (Guengerich and Holladay, 1979; French et al.,
1980; Dean and Gray, 1982; Myasoedova and Berndt, 1990;
Myasoedova and Tsuprun, 1993). The arrangement of purified,
detergent-free homomeric CYP1A2 (as well as CYP2B4) in
solution was defined by electron microscopy as being hexameric
with two layers of P450 trimers that are comprised of two
types of distinct P450–P450 interactions (Tsuprun et al., 1986;
Myasoedova and Tsuprun, 1993). Because of this characteristic
of P450s, it is expected that the enzymes would have a very
low KD for homomeric interactions in membranes. Using a
new approach to study P450–P450 interactions both physically
and functionally, CYP2C9 was covalently immobilized to a self-
assembled monolayer on gold film and its homomeric and
heteromeric interactions with CYP2D6, CYP3A4, and CPR
were monitored by surface plasmon resonance (Bostick et al.,
2016). This technique allowed interactions between immobilized
CYP2C9 and its binding partners in real time. From the data,
the KD constants for the various dimeric interactions were
calculated and ranged from 1 to 18 nM. Similarly, in a global
analysis of data derived from a thorough kinetic study involving
CYP2E1-mediated metabolism of para-nitrophenol over a range
of CYP2E1 and CPR concentrations, a KD of 38 nM was
approximated for the homomeric association of the CYP2E1
within a lipid milieu (Jamakhandi et al., 2007).
It should be pointed out that measurements of KD which
are based on volumetric concentrations, while providing a
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relative number that is more easily appreciated, are actually
not relevant to P450–P450 binding affinities that occur in
the two-dimensional lipid membrane (the interactions detected
by surface plasmon resonance actually did occur with the
enzymes in solution). Davydov et al. (2015) measured the two-
dimensional binding affinities for both the homomeric and
heteromeric interactions of CYP2E1, CYP3A4, and CYP3A5 by
luminescence resonance energy transfer (LRET) after each of
the pair of enzymes were variably labeled at cysteine residues
with LRET molecular partners. The binding constants [defined
as the P450 concentrations at which the fluorescence resonance
energy transfer (FRET) level reached 50% of the maximum]
for the various homomeric and heteromeric interactions ranged
from 0.07 to 0.56 pmol/cm2, and the corresponding two-
dimensional binding constant for homomeric CYP2E1 binding
was 0.16 pmol/cm2 [as compared to a KD of 38 nM (Jamakhandi
et al., 2007)]. In many cases, the heteromeric P450 associations
detected in these studies had higher binding affinities than the
homomeric interactions. Because the surface density of P450 in
the endoplasmic reticulum of mouse hepatocytes is estimated to
be in the range of 0.6–2.8 pmol/cm2 (Watanabe et al., 1993),
P450s are likely highly oligomerized in vivo.
Studies Measuring Rotational Mobility of
P450s
As summarized in our previous reviews (Reed and Backes,
2012; Brignac-Huber et al., 2016; Reed and Backes, 2016), the
literature provides many different lines of evidence that P450s
physically interact in lipid membranes by the application of
a variety of techniques that studied the rotational mobility of
P450s such as the following: (1) optical rotary diffusion (ORD)
following photolysis of the ferrous P450-CO complex with plane
polarized light (McIntosh et al., 1980; Gut et al., 1982, 1983;
Kawato et al., 1982; Iwase et al., 1991); (2) electron paramagnetic
resonance (EPR) of P450s containing cysteine groups that were
labeled with a maleimide containing a spin probe (Schwarz
et al., 1982); and (3) time-resolved polarized fluorescence of
cysteine residues in P450 that were labeled with diiodofluorescein
iodoacetamide (Greinert et al., 1982). Specifically, in these
studies, the mobility and rotation of P450s incorporated in
lipid bilayers of a given viscosity were compared with the
theoretical mobility and rotation for a monomeric sphere with
the approximate dimensions of the P450. These studies provided
useful information regarding certain characteristics of the P450
complexes in the lipid environment. These parameters were also
measured under conditions that would favor dissociation of P450
aggregates such as high lipid:P450 ratios (Kawato et al., 1982) or
high salt (Iwase et al., 1991).
When microsomes were studied or when P450s were
incorporated in artificial membranes at lipid:P450 ratios that
are comparable to those in the endoplasmic reticulum at
37◦C, there was a high proportion (approximately 50% or
higher) of aggregated P450 in the membrane as indicated by
immobilized protein over the time course of the experiments
(Gut et al., 1982; Iwase et al., 1991). Lower temperatures
favored higher proportions of immobilized P450s (Kawato
et al., 1982). Although these data did not provide specific
determinations of the sizes of the P450 aggregates, rotational
relaxation/correlation times suggest that the mobile fraction of
P450 in these microsomes and lipid bilayers is at least dimeric in
size (and probably larger) (Kawato et al., 1982), which in turn,
indicates that the immobilized fraction is represented by higher
degrees of aggregation, and the fluorescent study generated data
consistent with a rotating hexameric aggregate (Schwarz et al.,
1982). Interestingly, the fluorescent study indicated that changes
in the angle between orientation of the fluorescent label on
CYP2B4 and the plane normal to the membrane occurred upon
substrate binding and reduction by CPR. This was indicative
of functional changes in protein conformation (and not protein
aggregation) that could correspond to the change from the open
to the closed conformation of CYP2B4 [as determined in X-ray
crystal structures (Scott et al., 2003; Scott et al., 2004)].
The interaction of rabbit CYP1A2 and CYP2B4 is the
most studied P450–P450 interaction. For many substrates, the
functional effects of this interaction are stimulation of CYP1A2-
mediated activity and inhibition of that by CYP2B4 (Backes et al.,
1998; Reed et al., 2010). There is also evidence that CYP1A2 (and
other P450s) can form homomeric complexes (Reed et al., 2012).
Although rotational studies show that an excess concentration
of either lipid or CPR can disperse homomeric aggregates of
CYP1A (Iwase et al., 1991) and CYP2B4 (Gut et al., 1982) within
membranes, this does not diminish the significance of the high-
affinity heteromeric CYP1A2-CYP2B4 interaction in vivo (Backes
et al., 1998; Cawley et al., 2001).
Many P450–P450 hetero-interactions have been shown to be
resistant to disruption by CPR. The interaction of CYP2C9 with
both CYP2D6 and CYP3A4 (which both result in inhibition
of CYP2C9-mediated activity) was evidenced in the presence
of equimolar or excess CPR (if the P450s were mixed before
CPR was added) (Subramanian et al., 2009, 2010). The effect
of CYP2E1 on the apparent Km of CYP2B4 for metabolism
of benzphetamine also was observed when CPR concentrations
were in excess (Kenaan et al., 2013). Thus, some mixed P450
complexes are clearly refractory to dissociation upon the binding
of CPR. Taking into account these findings and the fact that
many heteromeric P450 interactions tend to display higher
binding affinities (discussed above), these interactions may occur
preferentially in biological membranes.
Cross-Linking Studies with P450s
Another method that has been used to demonstrate P450
complex formation in membranes and to estimate the size(s) of
P450 multimers is chemical cross-linking. There is some evidence
to suggest that the hexameric level of aggregation for P450s in
solution (Tsuprun et al., 1986; Myasoedova and Tsuprun, 1993)
(discussed above) may also exist when the P450s are incorporated
in membranes. Covalent crosslinking of CYP2B4, either in
detergent-free solution or when incorporated into lipid vesicles
of varying composition, generated virtually identical cross-linked
protein bands in terms of mass distribution and densities
(Myasoedova and Berndt, 1990). This suggests that the levels
of aggregation were similar for CYP2B4 under either condition.
This conclusion also was drawn from gel filtration studies with
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CYP2B1 showing that the aggregation state of the enzyme was
unaffected by its association with dilauroylphosphatidylcholine
(DLPC) (Rietjens et al., 1989).
Chemical cross-linking studies have shown that amine-
reactive cross-linkers generate high levels of cross-linked P450s
in incubations with purified, reconstituted systems (Reed et al.,
2010) (Myasoedova and Berndt, 1990). The cross-linked proteins
are characterized by a range of bands (dimeric to at least
tetrameric) with tight grouping of three or more closely migrating
bands for each size of oligomer when the samples are separated
by PAGE indicating that multiple amine groups are in close
proximity at the interface of the interacting P450s.
In contrast, studies of P450–P450 interactions using cysteine-
reactive cross linkers have generated only a limited sized range
of P450 multimers showing primarily dimeric (and in some
cases trimeric) associations without significant evidence of higher
levels of associations (McIntosh and Freedman, 1980; McIntosh
et al., 1980; Davydov et al., 2015). Thus, cysteine–cysteine
interactions between P450s may be more representative of
specific, evolutionarily conserved interactions between the P450s.
Certainly, this would seem to be the case for the homomeric
interaction of CYP2C8 as disulfide bonds between the cysteines
of adjacent protein units in CYP2C8 dimers helped stabilize the
interaction when the enzyme was expressed in cells (discussed
below).
Tsalkova et al. (2007) and Davydov et al. (2015) have designed
a number of studies regarding protein interactions involving
CYP3A4 that used site-directed mutagenesis to generate CYP3A4
mutants in which various cysteine residues in the enzyme were
substituted for serine or alanine. In one study examining cysteine
cross-linking with these mutants, the interaction of CYP3A4 was
suggested to be dominantly trimeric both in solution and in
membranes. Furthermore, the interaction apparently involved
two different types of contact between the trimer units as
indicated by the disappearance of the trimeric cross-linked band
in gel electrophoresis (leaving the cross-linked dimer as the
prevalent band) when one of the conserved cysteines was mutated
to a serine (Davydov et al., 2015). The cross-linking experiment
in this study also provided support for predictions of the
arrangement of units in CYP3A4 oligomers that were based on
examination of the X-ray crystal structure of the P450. Cysteine-
reactive cross-linking was also used effectively with site-directed
mutagenesis to demonstrate the dimerization of CYP2C8 and
to elucidate details regarding the quaternary structure of the
dimer (Hu et al., 2010). The details regarding the cross-linking
studies involving CYP3A4 and CYP2C8 are discussed below in
the section regarding the crystal structures of the P450s and
their relationship to the homomeric P450–P450 interactions in
membranes.
Fluorescent Studies with P450s
Studies with fluorescently labeled [or P450s labeled with probes
capable of fluorescence or luminescence resonance energy
transfer (LRET)] P450s have also revealed aspects of P450–P450
interactions. Originally, Davydov et al. (2001) used different
thiol-reactive fluorescent compounds to label the cysteine
residues in P450s and CPR. FRET involving the variably labeled
enzymes provided physical evidence for the interactions of
CYP1A2 and CYP2B4 in addition to their interactions with
CPR. This study provided physical evidence that the binding of
CYP1A2 and CPR was enhanced when the P450 was in a mixed
complex with CYP2B4, a finding that was predicted previously by
kinetic analyses of CYP1A2- and CYP2B4-mediated metabolism
as a function of the CPR concentration (Backes et al., 1998).
Luminescence resonance energy transfer and FRET
experiments have been useful in demonstrating the homomeric
interactions of CYP3A4 (Fernando et al., 2007; Davydov et al.,
2013, 2015). FRET caused by the binding of 1-pyrenebutanol to
the active site and its resulting interaction with the heme group
of a CYP3A4 mutant (that did not display cooperative binding
of the compound like the wild type enzyme) indicated a simple
binding equilibrium (Fernando et al., 2007). However, spectral
experiments using constant variation of substrate and enzyme
concentrations (Job’s titration) indicated enzyme oligomerization
influenced substrate binding. It was then shown that the binding
of apo form of the mutant CYP3A4 to the holo-enzyme resulted
in a loss of cooperative binding typically associated with the wild
type enzyme, and removal of the apo form restored cooperativity.
Luminescence resonance energy transfer of appropriately
labeled CYP3A4 CYS-depleted mutants (discussed above) was
also used to demonstrate that homomeric interaction of the
P450 possibly explained the heterotropic activation of CYP3A4-
mediated metabolism by α-naphthoflavone (ANF) (Davydov
et al., 2013). Interestingly, the effects of ANF and the
oligomerization of the P450s were coincident with high surface
density of the P450 in the proteoliposomes. The homomeric
oligomerization of the enzyme was cooperative as shown by the
LRET. Furthermore, using FRET to measure the interaction of
a fluorescent substrate with pyrene-labeled CYP3A4 at different
positions (in addition to the LRET technique), it was shown
that ANF (and other substrates) could affect the degree of
oligomerization of the enzyme at low protein concentrations
by binding to a peripheral, allosteric site on the enzyme that
was far removed from the active site (Tsalkova et al., 2007;
Davydov et al., 2012, 2013; Sineva et al., 2013). The effects of
ANF on enzyme oligomerization occurred over the same enzyme
concentration range that resulted in cooperative metabolism of
7-benzyloxy-4-trifluoromethylcoumarin by CYP3A4. Thus, the
heterotropic effects of ANF on CYP3A4-mediated metabolism
may relate to its ability to influence the oligomerization of the
P450 and may not be caused solely by altering substrate binding
through interactions within the active site as proposed previously
(Korzekwa et al., 1998; Shou et al., 2001; Houston and Galetin,
2005).
Luminescence resonance energy transfer was also used to
characterize the nature of P450–P450 interactions involving
CYP3A4, CYP3A5, and CYP2E1, and, as mentioned above, the
two-dimensional binding dissociation constants for each binary
combination were generated from these data (Davydov et al.,
2015). These data also demonstrated that the CYP3A protein–
protein interactions (but not those involving CYP2E1) were
cooperative with Hill coefficients ranging from 2 to 3.7. As
in the study with ANF, the cooperative homomeric interaction
of the LRET-labeled CYP3A was associated with cooperative
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metabolism of 7-benzyloxyquinoline by CYP3A. The study also
showed that the interaction of CYP2E1 with CYP3A resulted
in both stimulation of the kcat of CYP2E1-mediated metabolism
of 7-methoxy-trifluoromethylcoumarin and a decrease in the 7-
methoxy-trifluoromethylcoumarin binding affinity of CYP2E1.
This LRET study also implicated the likely quaternary structure
of the CYP3A4 multimer which is discussed in the section below
regarding P450 crystal structures.
Fluorescence resonance energy transfer and bimolecular
fluorescence complementation (BiFC) studies have been
invaluable in demonstrating specific homo- and hetero-
interactions of the enzymes of the P450 monooxygenase system
in natural membranes and in discerning the relative tendencies of
these labeled proteins to interact after co-expression in COS1 cells
and HEK293 T cells (Szczesna-Skorupa et al., 2003; Ozalp et al.,
2005). Briefly, FRET or BiFC pairs were co-expressed as fusion
proteins by linking the cDNAs of complimentary fluorescent
probes to the cDNA of the P450 system proteins. These studies
showed the homomeric interaction of CYP2C2 as well as its
interaction with the CPR. Although the interaction with CPR
could also be detected for CYP2E1, the homomeric interaction of
CYP2E1 was not detected in the cellular membranes. However,
the heteromeric interaction of CYP2E1 and CYP2C2 was
detected. The studies also were significant in showing the roles
of specific protein domains in mediating the protein-protein
interactions. The N-terminal, membrane-spanning domain was
critical for CYP2C2 self-oligomerization, whereas the cytosolic
domain (N-truncated form of the enzyme) was implicated in
the interactions of CYP2C2 with both the CPR and CYP2E1.
These findings again support the assumption that heteromeric
P450–P450 interactions occur more readily than homomeric
interactions.
Positional Heterogeneity of P450–P450
Complexes
One of the most striking attributes of P450–P450 complexes
is their stability over time. This trait is ultimately responsible
for the functional effects of P450–P450 interactions and has
been demonstrated by many studies. A koff for the dissociation
of CYP2B4 oligomers was calculated in the FRET study by
Davydov et al. (2001) (discussed above) by measuring the rate
of change in FRET after mixing two populations of CYP2B4
in which the sulfhydryl groups were labeled with different
fluorescent probes. The very low value for koff calculated in this
experiment was 0.44 h−1. Interestingly, the quasi-irreversible
nature of the heteromeric interactions of CYP2D6 and CYP2C9
also were demonstrated functionally by showing that the changes
in metabolism caused by the interaction of the enzymes could
be influenced by the order that P450s and CPR were added to
the reconstituted system (Subramanian et al., 2009). Excess CPR
could only attenuate inhibition of CYP2C9-mediated activity,
caused by its interaction with CYP2D6, when CPR was added
concurrently or before addition of the second P450 and not when
the two P450s were added before the CPR.
“Positional heterogeneity” (or “persistent conformational
heterogeneity”) of P450–P450 complexes are synonymous terms
that have been used to describe the quasi-irreversible nature
of P450–P450 complexes (Davydov, 2011; Davydov et al.,
2015). Davydov, working with various researchers, has clearly
demonstrated the significance of this trait using a variety of
approaches. Initially, heterogeneity in the CYP2B4 homomeric
complex was demonstrated by hyperbaric studies of the ferrous
CYP2B4-CO complex (Davydov et al., 1995). This study
indicated that a specific population of the CYP2B4 subunits in
P450 multimers was susceptible to a pressure-induced conversion
to P420. The different populations of CYP2B4 also could be
distinguished by the equilibrium between low and high spin
forms of the enzymes, a transition that occurs very rapidly unless
the spin state of the enzyme is “frozen” through the quasi-
irreversible interaction with other P450s. Evidence that these
traits were associated with multimeric enzyme complexes was
demonstrated by loss of enzyme heterogeneity when the P450 was
treated with detergent. Given that P450 half-lives range from 4 to
37 h (Zhukov and Ingelman-Sundberg, 1999), quasi-irreversible
P450–P450 interactions could have a profound influence on drug
metabolism.
The interaction of CYP1A2 and CYP2B4 was initially inferred
by its functional effects by Backes in the mid to late 1990s (Cawley
et al., 1995; Backes et al., 1998). These studies showed that upon
interaction of the two P450s, CYP2B4-mediated activity was
inhibited, whereas that of CYP1A2 was dramatically activated.
Davydov provided physical evidence for the formation of this
complex using the hyperbaric technique (Davydov et al., 2000b).
In this study, P450 stability as a function of pressure was
compared for CYP1A2 and CYP2B4. Unlike CYP2B4, the ferrous
CYP1A2-CO complex did not demonstrate a susceptibility to
convert to P420 under increasing pressure. More importantly,
when CYP1A2 and CYP2B4 were pre-incubated for 9 h (but
not when measurements were made immediately after mixing
the P450s), the barotropic instability of CYP2B4 disappeared
and the peak absorption of the Soret band of the CYP2B4-
CO complex shifted from 450 to 448 nm, similar to that of
CYP1A2. Furthermore, there was a “steeper” dependence of
spin state change to the change in pressure when the CYP2B4
was in a complex with CYP1A2 indicating greater hydration
of the CYP2B4 active site as a result of its interaction with
CYP1A2.
More recently, Davydov et al. (2016) conducted a hyperbaric
study to demonstrate a pressure-induced conformation
change in CYP3A4 that was either dual-labeled with a LRET
donor/acceptor pair or an electron spin probe. It was determined
that only approximately 15% of the CYP3A4 population
adopted the “high pressure” conformation at ambient pressure.
Furthermore, the allosteric activator, testosterone, caused a shift
to this “high pressure” conformation when bound to the enzyme.
By selective modification of the protein with fluorescent and
nitroxide side-chain spin probes, the region of the CYP3A most
affected by the conformation changes was defined as the regions
involving the α-helices, A/A′, and the meander loop and was
shown to correspond to open and closed states of the enzymes.
The pressure-induced conformation change was consistent
with the putative change in the oligomeric state of the enzyme
associated with ANF and other allosteric activators (discussed
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above) indicating that the conformational state of the protein is
intimately related to its state of aggregation.
Conformational heterogeneity of many P450s has also been
explored by using CO-flash photolysis of the ferrous CO-P450
complex (Koley et al., 1994, 1995, 1996, 1997). Because the CO-
complex that absorbs maximally at 450 nm is photo-sensitive, the
kinetics of CO-rebinding to a P450 can be monitored on a rapid
time scale by stopped flow spectrophotometry after subjecting
the complex to a flash of white light. In the study with CYP3A4
(Koley et al., 1995), the experiments clearly demonstrated three
populations of enzymes corresponding to three conformations
of the enzyme. Furthermore, the equilibrium between the
conformers was influenced by the substrate bound to the enzyme.
These results are quite consistent with the findings regarding
CYP3A4 oligomerization and heterogeneity by Davydov and co-
workers (discussed above). Specifically, a trimer of the P450 was
implicated in which there was a conformational equilibrium that
was influenced by substrate/effector binding.
Positional heterogeneity of P450 multimers has also been
demonstrated by the multiphasic, time-dependent chemical
reduction of populations of CYP2B4 (Davydov et al., 1985) and
of CYP3A4 (Davydov et al., 2005) by dithionite. Subsequent to
measuring the chemical reduction of CYP3A4, heterogeneity in
the CYP3A4 multimer was demonstrated by its time-dependent,
enzymatic reduction using the soluble reductase domain of
the bacterial P450, BM3 (Fernando et al., 2008). These studies
showed the rate of reduction was related to the spin state of
the enzyme. The low spin form was chemically reduced most
rapidly; whereas, high spin form was more rapidly reduced
enzymatically indicating this form preferentially interacted with
the redox partner. These studies showed that the differences
in reduction due to spin state were related to heterogeneity
within the enzyme oligomer by using detergents to disperse
the P450 multimers whereupon the reduction of P450 became
monophasic with respect to time. The solubilized P450 was
refractory to a substrate-induced spin state change. However, the
study examining chemical reduction of CYP3A4 by dithionite
also utilized nanodiscs to disperse the CYP3A4. Nanodiscs utilize
phospholipid and a membrane scaffolding protein that allows
for the stabilization of small, discoidal lipid-bilayer particles
that are reported to contain monomeric enzyme when mixed at
appropriate relative concentrations (Baas et al., 2004). This was
significant because nanodisc-incorporated CYP3A4 was capable
of a substrate-induced spin state change (Baas et al., 2004). More
recent studies have indicated that CYP3A4 incorporated into
nanodiscs with CPR also was catalytically active (Grinkova et al.,
2010; Denisov et al., 2015). Thus, the monomeric state of the
P450 was not necessarily inactive as might be concluded from the
studies using detergents to disperse the P450.
THE RELEVANCE OF P450 CRYSTAL
STRUCTURES TO P450–P450
INTERACTIONS IN MEMBRANES
Because of the lack of detail concerning the arrangement of P450s
in their multimeric form, the crystal structures and lattices have
been interpreted for their potential relevance to the functional
effects of P450–P450 interactions. This approach also has been
used in a previous study (Hazai et al., 2005). Of the four types of
P450–P450 interactions that were evaluated in the prior study,
it was concluded that none of the regions involved in binding
for a given P450 dimer overlapped with the regions involved in
other types of dimers. Thus, there was the potential for large
aggregates to be built from the different types of dimers, and any
given aggregate could be characterized by a variety of P450–P450
contacts.
The assumption in drawing inferences from P450 crystal
structures is that each type of P450 has a tendency to arrange
itself in characteristic associations that also may be observed in
solution and in lipid membranes. As the crystal structures are
generated from soluble P450 mutants that lack the N-terminal,
membrane-spanning sequence and thus, are favorable to the
formation of crystals, there is some uncertainty about the
relevance of these structures to P450–P450 interactions within a
lipid milieu. Speculation about the quaternary structure of mixed
P450 complexes is even more problematic given that crystal
structures for mixed P450 complexes do not exist. Despite the
limitations of the approach, P450 crystal structures reveal some
intriguing interactions that could explain some of the functional
effects related to the physical interactions of different P450s.
In order to discuss the potential significance of arrangements
in P450 crystal lattices, it is necessary to provide a basic
description of the prominent structural features of the P450
protein. The enzymes are comprised of approximately 460
amino acids making up a series of α-helices, β-sheets, and
interconnecting regions that are organized around a central heme
prosthetic group. The drug-metabolizing P450s are tethered to
the membrane by the insertion of a hydrophobic, N-terminal
tail. The N-terminal region is connected to the structural core of
the protein, known as the catalytic domain, via the polar linking
region that contains several cationic amino acids and protrudes
out the cytosolic side of the membrane.
It has been postulated that the polar linking region would
be positioned to interact with the anionic charges of the
phosphate groups in membrane lipids as a means to modulate
membrane positioning of the P450s (Ozalp et al., 2006) and
presumably, the interaction with redox partners and other
P450s. Both the membrane penetration and α-helical content of
CYP1A2 were increased in the presence of anionic phospholipids
(Ahn et al., 1998), and these changes may be attributable to
stronger electrostatic interactions between the negatively charged
phospholipids and the positively charged, polar linking regions
of this P450. Furthermore, these protein-lipid interactions may
allow for tighter packing of the polar linking regions between
adjacent P450s as they might minimize the repulsion between the
like-charged, cationic amino acids in the polar linker regions of
adjacent enzymes. The cross-linking results with amine-reactive
cross-linkers (discussed above) would be consistent with covalent
bonds involving this region in adjacent protein units of P450
multimers. Interactions involving this region also have been
implicated in a membrane-bound, dimeric CYP2C8 complex
(discussed below). Interestingly, electrostatic interactions have
been implicated in the homomeric interaction of CYP1A2 that
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causes inhibition of the enzyme (Reed et al., 2012) and have
been shown to be involved in both the heteromeric CYP1A2-
CYP2B4 (Kelley et al., 2005) and CYP1A2-CYP2E1 (Kelley et al.,
2006) interactions. Future work is needed to show whether the
electrostatic interactions between lipids and the polar linking
regions are those responsible for these P450–P450 interactions.
P450s are wedge-shaped with two prominent sides that have
important functional roles and are identified by their relative
orientation with respect to the heme group. The distal side
(relative to the heme group) protrudes out from the heme
and contains the F and G helices that form the outer wall
of the substrate binding cavity. For many P450s, the B-C
loop and F-G loop/minor helices region between the F and G
helices has been shown to play a role in substrate recognition
(Ibeanu et al., 1996; Williams et al., 2004; Pochapsky et al.,
2010). Studies examining P450s in nanodiscs indicate that the
monomeric enzyme is tilted at an angle with respect to the
membrane surface with the distal region partially buried in
the membrane along with the hydrophobic, N-terminal tail of
the P450 (Baylon et al., 2013). Indeed, truncated P450s lacking
the N-terminal tails interact with membranes by virtue of the
F-G region (Pernecky et al., 1993; Pernecky and Coon, 1996;
Williams et al., 2000a; Scott et al., 2001). P450s demonstrate
conformational flexibility, and dramatically different open and
closed structures involving primarily changes in the positions of
the B-C loop and the F-G helices have been identified for some
P450s (Scott et al., 2003; Ekroos and Sjogren, 2006; Roberts et al.,
2010).
The other prominent face of the P450 is the proximal side
of the enzyme. This surface constitutes a broad, flat area with
multiple, positively charged residues that facilitate interaction
with and electron transfer from the redox partners, CPR and
cytochrome b5 (Tamburini et al., 1986; Bridges et al., 1998;
Sevrioukova et al., 1999; Davydov et al., 2000a). The results with
amine-reactive cross-linkers may also implicate this region as
the interface of P450 multimers. In the section below regarding
P450 crystal structures, proximal-to-proximal interactions are
observable in the crystal lattices of some P450s and may
explain some of the functional effects attributable to P450–P450
interactions.
When considering the potential functional consequences of a
protein–protein interaction using the crystal structure as a model,
it is important to only consider crystal structure interactions
in which the N-terminal ends of the interacting P450s can be
contained in a single plane (representative of the surface of
the membrane lipid bilayer) that does not intersect the center
of the interface of the interacting units or have the two (or
more) proteins projecting outward from opposite sides of the
imaginary plane. Structures not meeting these criteria would not
likely be plausible in vivo (unless P450s could interact on the
opposing folds of the endoplasmic reticulum membrane) given
the physical constraint that the P450s are known to be tethered to
the membrane by the N-terminal tails.
Quaternary structures that have been elucidated from the
crystal structures in this study have also been evaluated
using the program, PDBePISA (Proteins, Interfaces, Structures,
and Assemblies) (European Bioinformatics Institute, Hinxton,
England). This algorithm evaluates the interfaces of protein–
protein contacts within the crystal to assess their potential
stability within the membrane and also predicts the sizes of
complexes that would be formed from these intermolecular
interactions. The strength of the interaction is evaluated based
on the number of potential hydrogen bonds, salt bridges, and
disulfide bonds that can be detected within the interaction and
is quantified by a Complex Significance Score (CSS) that ranges
from 0 to 1 (with 1 being a strong interaction). The analysis
can also determine the interface area of the contact and the
number of interacting residues between protein units for any
given arrangement in the crystal.
Interestingly, evaluations of P450–P450 interactions using this
program generally predict that the proteins exist as monomers
(CSS scores close to 0) despite the preponderance of evidence
for multimeric P450s in membranes (as described above). In
conjunction with this trend, none of the P450–P450 complexes
we evaluated in this study were predicted to be stable in the
membrane (shown in Table 1) even though the direct evidence
suggests that quaternary structures very similar to those identified
from the CYP2C8 (Figure 1) and CYP3A4 (Figure 2) crystal
structures have been demonstrated in membranes (as discussed
below). The uncertainties regarding the in silico interpretation
of intermolecular interactions may reflect the importance of the
N-terminal, hydrophobic tails (which are absent in x-ray crystal
structures of P450s) in stabilizing P450–P450 complexes in the
membrane.
Examination of the available crystal lattices of P450s shows
many different types of plausible interactions that could exist in
the membrane including distal-to-distal, proximal-to-proximal,
and those involving the sides between the proximal and distal
faces of the enzymes. Interactions involving the sides between
distal and proximal faces of a P450 will be referred to as side-on
or side-to-side interactions. These side-on interactions also can
involve contacts between the proximal and distal regions of the
interacting partner. Direct interactions between the proximal and
distal sides are not commonly observed in the crystal structures
for mammalian P450s. However, this arrangement has been
identified in the crystal structure of the bacterial reductase-P450
fusion protein, BM3 (Ravichandran et al., 1993). Our analysis
will start with examples of crystal structures that have been
demonstrated to be likely representations of the homomeric
interactions of certain P450s in membranes.
Homomeric Crystal Structures That have
been Supported by Data in Cellular
Systems
Homomeric CYP2C8
Computer modeling and hydropathy analyses indicate that
lipophilic P450 substrates presumably enter the active site via
the B-C loop and F-G helices region in the membrane, and the
P450-generated products exit through a solvent access channel
often found between the F and I helices (Petrek et al., 2006, 2007;
Cojocaru et al., 2011). Thus, the distal region plays an important
role in substrate binding to most mammalian P450s. A distal-to-
distal arrangement in P450 crystal structures has been observed
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TABLE 1 | Binding characteristics of the different homomeric complexes of P450 shown in the figures as determined from PISA analysis.
Complex Figure # Nature of complex Nresa Interface area (Å2) 1iGb kcal/mol NHBc NSBd NDSe CSSf
CYP2C8 Figure 1 Distal-to-distal 11 265.6 −2.2 4 2 0 0.000
CYP3A4 Figure 2 Distal-to-distal 17 444.9 −6.4 0 0 0 0.000
CYP1A2 Figure 3 Proximal-to-proximal 17 523.6 1.3 0 0 0 0.000
CYP2B4 (closed form) Figure 4 Interface 1g Side-to-side 26 644 0.4 4 2 0 0.000
CYP2B4 (closed form) Figure 4 Interface 2g Side-to-side 25 789 −4.5 1 0 0 0.000
CYP2B4 (open form) Figure 5 18 290 2.6 4 2 0 0.000
CYP3A4 (open form) Figure 6 Proximal-to-proximal 20 469 −1.1 4 0 0 0.000
CYP2C9 Figure 7 Proximal-to-side 21 553.1 3.8 5 6 0 0.000
CYP2C19 Figure 8 Side-to-side 11 359.7 −4.4 3 0 0 0.047
CYP2C9 Figure 9h Hexameric 17 398.3 −1.2 4 1 0 0.000
The binding characteristics of P450 homomeric complexes shown in Figures 1–9 were determined by using the program PDBePISA (EMBL-EBI, Hinxton, England).
aNres – The number of interacting residues in the complex. b1iG – the solvation free energy gain upon formation of the interface of the P450–P450 complex. cNHB – The
number of hydrogen bonds detected. dNSB – The number of salt bridges detected. eNDS – The number of disulfide bonds detected. fCSS – Complexation significance
score. gFigure 4 depicts a trimer of CYP2B4. Interface 1 corresponds to the interaction of the center unit with the left-most unit of CYP2B4, whereas interaction 2
corresponds to the right-most interaction. hThe figure represents a hexamer of CYP2C9. The interactions comprising the “arms” of the hexamer are those depicted in
Figure 7. Thus, the values shown for Figure 9 represent those for the central interacting units of the hexamer.
FIGURE 1 | Crystal structure of dimeric form of CYP2C8 bound to
palmitate (PDB: 1PQ2). The units of the dimer are oriented with the
N-terminal region (shown in blue) at the base of the dimers in a “membrane
plane” running perpendicular to the plane of the image. The heme groups are
shown as red spheres with α-helices drawn as cylindrical features. The dimers
are joined at F-G loop region. The F-G helices on the surface of the distal
faces of the dimer are shown in yellow. Two molecules of palmitate bound on
the periphery of the active site at the junction of the dimer are shown in pink.
All molecular structures in this study were generated in PyMOL v. 1.8.4.1
(Schr dinger, Cambridge, MA, USA).
with many different drug-metabolizing P450s including CYP3A4
(1W0F), CYP1A2 (PDB: 2HI4), CYP2D6 (PDB: 2F9Q), CYP2A6
(PDB: 2FDV), and the open form of CYP2B4 (PDB: 1PO5).
Recent studies involving CYP2C8 (PDB:1PQ2) (Hu et al., 2010)
and CYP3A4 (Davydov et al., 2013, 2015) have provided evidence
that this type of dimer is also formed from the homomeric
interactions of these P450s when they are membrane-bound.
Studies with purified CYP2C8 in which Trp residues were
introduced by mutagenesis in order to examine the interaction
(by Trp fluorescence quenching) of the mutated P450 with
spin-labeled lipids in artificial membranes (Ozalp et al., 2006)
FIGURE 2 | Crystal structure of distal-to-distal dimeric form of CYP3A4
bound to progesterone (PDB: 1W0F). The units of the dimer are oriented
with the N-terminal region (shown in blue) at the base of the dimers in a
“membrane plane” running perpendicular to the plane of the image. The heme
groups are shown as red spheres with α-helices drawn as cylindrical features.
The F-G helices region indicating the distal surface is shown in yellow. The
peripheral effector site for binding of two molecules of progesterone are
shown in pink.
suggested that the F-G loop did not interact with the membrane
as predicted from similar studies with human CYP2J2 (McDougle
et al., 2015) and hydropathy analysis of a similar CYP2C
enzyme (Williams et al., 2000b). Interestingly, this region also
was the major point of interaction in the dimeric X-ray crystal
structure of CYP2C8 (PDB:1PQ2; Figure 1; Table 1). It was
predicted from the crystal structure that the dimerization
would be facilitated by adjacent sulfhydryl groups in cysteine
residues of the interacting CYP2C8 units. Dimerization was
then demonstrated on electrophoretic gels after either oxidation
or cross-linking of the cysteine residues on CYP2C8 that was
transiently expressed in bacterial membranes and in AD-293 cells
(Hu et al., 2010). Subsequent mutagenesis experiments indicated
that dimerization through the sulfhydryls was dependent on
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having cysteine residues within either the polar linker sequence
(between the N-terminal, membrane-spanning region and the
catalytic domain) or the F-G loop. Thus, these regions were
implicated as the points of contact in the membrane-bound
CYP2C8 dimer.
Dimerization through the sulfhydryls was not observed in the
cell membranes when the hydrophobic N-terminal membrane
anchor was deleted or substituted with a hydrophilic N-terminal
sequence. This is consistent with BiFC (Ozalp et al., 2005)
and FRET (Szczesna-Skorupa et al., 2003) studies of the closely
related CYP2C2 in COS1 cells (discussed above) showing that
homomeric P450–P450 interactions required the N-terminal
membrane domain. Similarly, N-terminal truncation prevented
the interaction of CYP3A4 and CYP2C9 (Subramanian et al.,
2010). Thus, the N-terminal region is very important in
stabilizing some P450–P450 interactions in the membrane.
Interestingly, the arrangement of subunits in the crystal
structure of CYP2C8 were such that the cysteines in the polar
linker regions of adjacent units did not align in close enough
proximity to allow for disulfides and/or cross linking to occur
between the units. In fact, for the polar-linking regions of the
dimer units to be in close proximity, the F-G loop would have
to be pulled out of the membrane. Thus, dimers with similar
features were apparently formed with both full-length CYP2C8
in membranes and with truncated CYP2C8 in solution. However,
the membrane interaction that is stabilized by the N-terminal
sequence of the full-length form imparts a slight change in
alignment within the dimer that allows for cross-linking through
adjacent sulfhydryls in the polar linker region. It was speculated
that the high enzyme concentrations needed to form CYP2C8
crystals facilitated dimerization even without the N-terminal
sequences. However, the N-terminal segment was needed for
stabilization of the dimer after transient expression of the enzyme
in cellular membranes. Unfortunately, the functional effects of
the CYP2C8 homomeric interaction were not assessed. However,
as discussed above, movement of the F-G loops, which form part
of the substrate access channel from out of the membrane bilayer
upon the formation of the dimer, would undoubtedly influence
the binding of substrate by the enzyme.
Homomeric CYP3A4 and Its Functional Effects
CYP3A4 is quantitatively the most important P450 in drug
metabolism (Anzenbacher and Anzenbacherová, 2001;
Guengerich, 2003). As a result, considerable effort has been
devoted to resolving crystal structures for this enzyme, and a
number of conformations have been identified for the P450
when bound to different compounds (Williams et al., 2004; Yano
et al., 2004; Ekroos and Sjogren, 2006). Several lines of evidence
have suggested that a dimeric arrangement of CYP3A4 in the
crystal lattice has functional relevance to the multimeric state
of the membrane-bound enzyme. The quaternary structure is
unusual because it has two molecules of progesterone bound to a
peripheral “cleft” formed in the interface of a homomeric dimer
[PDB: 1W0F; Figure 2)]. Interestingly, the CYP2C8 crystal dimer
(PDB: 1PQ2) also displayed a peripheral binding site for two
palmitate molecules in a similar location to that of the CYP3A4
dimer, but its functional significance was not explored.
Davydov et al. (2016) have now provided evidence from
studies using LRET/FRET and chemical cross-linking that the
CYP3A4 crystal dimer is a reasonable analog to a quaternary
structure adopted in the membrane. First, it was described above
how FRET/LRET studies indicated that the binding of ANF
to CYP3A4 could change the oligomeric state of the enzyme.
FRET was also measured after mixing different combinations
of specific cysteine-depleted mutants that were variably labeled
with donor/acceptor FRET pairs (Tsalkova et al., 2007; Sineva
et al., 2013). From dramatic FRET changes upon the binding
of the effector, ANF, it was possible to prove a change in
conformation that was not elicited when a prototypical substrate
bound to the heme active site. These findings are consistent with
the hyperbaric study (described above) monitoring a pressure-
dependent conformation change in CYP3A4 that was facilitated
by the allosteric effector, testosterone (Davydov et al., 2016).
Using another approach, the FRET/LRET efficiencies and the
F rster radius of the donor/acceptor pair, it was possible to
approximate the separation distance between adjacent cysteines
on an interacting pair of variably labeled CYP3A4 cysteine
mutants (Davydov et al., 2015). For each pair of mutants, the
calculated distances between the cysteine locations were within
the range of error of the distances that would be expected in the
progesterone-bound crystal. Similarly, by using cysteine-reactive
cross-linkers of different lengths with the CYS-depleted CYP3A4
mutants in order to explore the distance between adjacent
cysteines in CYP3A4 multimers, it was possible to demonstrate
that the results were also consistent with the progesterone-bound
CYP3A4 structure. From these studies, it was proposed that ANF
and other effectors bound to the same peripheral site bound
by progesterone in the implicated crystal structure, and that its
binding changed the oligomerization state of the enzyme and
in turn, its catalytic activity. From the crystal structure, it was
proposed that the progesterone-binding site could play a role in
initial substrate recognition because it lines up with a suitable
route (through the F-G helices region) from the membrane to
the active site (Williams et al., 2004). Thus, in light of the other
biophysical data, the conformation change required to open up
this putative channel may be facilitated by interactions with the
peripheral ligand. Interestingly, the less catalytically active form
of CYP3A4 in the absence of effector binding may also be a
distal-to-distal dimer (from crystal structure PDB:1W0G). Thus,
the change in oligomerization caused by effector binding to the
peripheral binding may only be a subtle repositioning of the
dimer that opens up a putative substrate access channel through
the F-G helices region and not necessarily a change from the
monomeric state to a multimeric enzyme complex.
Metabolism by CYP3A4 is often characterized by sigmoidal,
homo-, and heterotropic cooperativity (Korzekwa et al., 1998;
Shou et al., 2001; Houston and Galetin, 2005). One of the best
examples of heterotropic cooperativity involves the effects of
ANF on CYP3A4-mediated metabolism. This compound often
activates metabolism by eliminating sigmoidal enzyme kinetics.
Until recently, cooperativity was attributed to a large active
site that is capable of binding multiple substrates. Effector
compounds could thus influence positioning of a substrate (and
in turn its metabolism) by simultaneous binding to the active
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site. It has also been postulated that effector binding may elicit
a change in CYP3A4 conformation that is more catalytically
active. In support of these ideas are crystal structures of CYP3A4
(Ekroos and Sjogren, 2006) showing multiple compounds
within the active site (PDB: 2V0M) as well as variations in
conformation upon binding to different substrates (PDB: 2J0D).
Various biophysical techniques also indicate a ligand-influenced
equilibrium between multiple conformations of the enzyme
(Koley et al., 1995; Sineva et al., 2013; Davydov et al., 2016). In
addition, studies with CYP3A4, reconstituted in nanodiscs with
excess CPR, observed both homotropically cooperative substrate
binding (Baas et al., 2004) and heterotropically cooperative
substrate metabolism (Denisov et al., 2015).
In contrast, the LRET/FRET studies with CYP3A4 described
above suggest that effector-induced changes in protein
conformation lead to changes in protein oligomerization, and it
may in fact be the latter changes that directly relate to cooperative
metabolism by CYP3A4. The relative roles that effector-mediated
substrate re-positioning in the active site and effector-mediated
changes in protein conformation/oligomerization play in causing
cooperative CYP3A4-mediated metabolism have not yet been
determined. However, one of the objectives of this review is
to entertain the possibility that many functional changes of
P450–P450 interactions could simply be explained by positional
changes of enzyme units in P450 multimers and not solely by
changes in enzyme conformation and substrate-positioning
within the active site.
Using Positional Re-arrangement within
P450 Multimers to Explain the Functional
Effects of P450–P450 Interactions
The reported functional effects involving a given P450 that are
caused by its interaction with another P450 will be considered
with respect to any distinctive features observed in the crystal
lattice arrangement of the P450 that may impart functional
properties to the homomeric complex. The validity of this
approach lies in the fact that any discussion about the functional
effects of P450–P450 interactions is relative to the frame of
reference. As discussed in detail above, the P450 units in
homomeric multimers are not identically distributed within the
aggregate but are characterized by different spin states and
different abilities to be reduced/bind substrates. Furthermore,
the transition between subunit positions within the aggregate
is extremely limited or hindered as indicated by removal of
a segment of the P450 population from the rapid spin state
equilibrium. Thus, any aggregate of P450 is inhibitory by nature
of the fact that some of the units in the aggregate may not
be fully functional. With this in mind, any heteromeric P450–
P450 interaction that causes activation of a P450 could be due to
the homomeric interactions of the affected P450 being relatively
inhibitory. Conversely, inhibitory P450–P450 interactions would
be related to subunit arrangements in the hetero-complex
that contrast with those associated with higher functionality
in the homomeric complex. Studies that have elucidated the
kinetic mechanisms by which P450–P450 interactions influence
metabolism will be used to explain how specific homomeric
interactions may be more or less functional.
P450–P450 Interactions That Influence
CPR Binding
CYP1A2 Interactions
Several studies have demonstrated that the ability of a P450 to
bind CPR is altered when it forms a mixed complex with another
P450. For the P450–P450 interactions of CYP1A2-CYP2B4
(Backes et al., 1998), CYP1A2-CYP2E1 (Kelley et al., 2006),
CYP2C9-CYP2C19 (Hazai and Kupfer, 2005), and CYP2E1-
CYP2B4 (Kenaan et al., 2013), CYP1A2 and CYP2C9 (and
CYP2E1 in its interaction with CYP2B4) were able to bind CPR
more readily (and thus be more catalytically active) when bound
to the indicated P450s; whereas the ability of the interacting
P450 to bind CPR was either inhibited or unaffected. If one only
considers the relative positions of the protein “units” in a P450
multimer (and not necessarily the conformation of the enzyme as
a determinant in its activity), CPR binding could most logically
be affected by interactions involving the proximal side of the P450
enzyme sterically disturbing formation of the CPR·P450 complex
and consequently electron transfer.
Thus, taking the CYP1A2-CYP2B4 interaction as the most
well-studied example of this effect and the line of reasoning
used in the introductory paragraph to this section, the activation
of CYP1A2 via enhanced CPR binding in mixed P450–P450
complexes would imply that its homomeric complex is limited
in its ability to bind CPR. In support of this conclusion, research
from our lab has clearly demonstrated that the homomeric
interaction of CYP1A2 inhibits its activity by a mechanism that
involves a lower CPR-binding affinity (Reed et al., 2012). In
these studies, CYP1A2 activities showed a sigmoidal response
as a function of CPR concentration, which is consistent with a
CYP1A2·CYP1A2 dimer that is inactive (Reed et al., 2012).
Interestingly, a proximal-to-proximal interaction is very
prevalent in the crystal lattice for CYP1A2 (PDB: 2HI4, Figure 3).
With this proximal-to-proximal arrangement, the units in the
CYP1A2 dimer directly overlay the proximal face of the identical
binding partner in a manner that would completely prevent
access for CPR binding. Thus, the stimulation of CYP1A2
caused by heteromeric P450 interactions (with either CYP2B4
or CYP2E1) may stem from the CYP1A2 having a different
arrangement with its proximal face exposed in the presence of
these other P450s. This in turn, would cause a higher proportion
of the CYP1A2 to be available to functionally interact with CPR.
Proximal-to-Proximal Interactions with
Open Conformations of P450s
The proximal-to-proximal interaction is very unusual in closed
forms of P450s. For instance, the closed conformation of CYP2B4
(PDB: 1SUO) is predominated by side-to-side interactions
(Figure 4). However, a proximal-to-proximal interaction is
observed in the crystal lattice of an open form of CYP2B4
(PDB:1PO5; Figure 5A). The open form of this P450 was
crystallized as a distal-to-distal dimer (Figure 5B). This
conformation of CYP2B4 adopts many different arrangements
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FIGURE 3 | Crystal structure showing lattice arrangement of
proximal-to-proximal dimer of CYP1A2 bound to the inhibitor, ANF
(PDB:2HI4). The units of the dimer are oriented with the N-terminal region
(shown in blue) at the base of the dimers in a “membrane plane” running
perpendicular to the plane of the image. The heme groups are shown as red
spheres with α-helices drawn as cylindrical features. The bound ligand, ANF is
shown in the active site in a pink color. The F-G helices region on the distal
face of the enzyme is shown in yellow.
FIGURE 4 | Crystal structure showing side-to-side lattice arrangement
of a CYP2B4 trimer of closed form CYP2B4 with
4-(4-chlorophenyl)imidazole (shown in pink) bound to the active site
(PDB:1SUO). The units of the trimer are arranged with the N-terminal ends
(shown in blue) at the base of the units in a “membrane plane” running
perpendicular to the plane of the page. Regions involved in the interactions
include the G-, H-, J-, C-, and D-helices. The heme groups are shown as red
spheres with α-helices drawn as cylindrical features. The F-G helices region
on the distal face of the enzyme are shown in yellow.
in its crystal structure including two types of side-to-side
interactions in addition to the distal-to-distal and proximal-to-
proximal orientations. The open-form, intercalated, distal-to-
distal dimer represents an inactive complex having a His in
the F-helix of one open unit coordinating with the active site
heme of the other open CYP2B4 unit. An evaluation of the
open conformation of the CYP2B4 crystal structure led to the
conclusion that this form of CYP2B4 also would be deficient in
functionally interacting with CPR because of repositioning of
the C helix (Scott et al., 2003). Thus, whether or not the open
CYP2B4 is in a proximal-to-proximal interaction, it is probably
FIGURE 5 | The crystal structure of open-formed, ligand-free CYP2B4
(PDB:1PO5) showing lattice arrangements of a proximal-to-proximal
dimer (A) and an intercalated, distal-to-distal dimer (B). The units of the
dimers are oriented with the N-terminal region (shown in blue) at the base of
the dimers in a “membrane plane” running perpendicular to the plane of the
image. The heme groups are shown as red spheres with α-helices drawn as
cylindrical features. The F-G helices regions on the surface of the distal faces
of the enzyme units are shown in yellow.
not reducible by CPR. In the inhibition of CYP2B4 caused by
its interaction with CYP1A2, it seems conceivable that the effect
could be due in part, to a proximal-to-proximal association of
open form CYP2B4 with CYP1A2 in which the CYP2B4-binding
site for CPR is blocked. The hyperbaric studies of the CYP1A2-
CYP2B4 complex (Davydov et al., 2000b) showed that there was
increased hydration of the active site of CYP2B4 as a result of its
interaction with CYP1A2 which is consistent with the interaction
involving the open form of CYP2B4.
A proximal-to-proximal interaction can also be observed
in the crystal lattice of an open form of CYP3A4 bound to
ketoconazole (PDB: 2V0M; Figure 6) (Ekroos and Sjogren,
2006). Furthermore, the crystal structure of the open CYP3A4
dimer associated with the binding of erythromycin is arranged
in an offset proximal-to-proximal orientation (PDB: 2J0D). As
is the case with CYP2B4, proximal-to-proximal interactions
of the open CYP3A4 are not observed in crystal lattices of
closed CYP3A4 forms (discussed above). CYP3A4 metabolizes
very large substrates, and the open form apparently is adopted
when large substrates are metabolized by the P450. Thus, unlike
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FIGURE 6 | Crystal structure showing lattice arrangement of
proximal-to-proximal dimer of open-formed CYP3A4 with two
molecules of ketoconazole bound to each active site (shown in pink)
(PDB:2V0M). The units of the dimer are oriented with the N-terminal region at
the base of the dimers in a “membrane plane” running perpendicular to the
plane of the image. The heme groups are shown as red spheres with
α-helices drawn as cylindrical features. The two ketoconazole molecules
bound to each active site are shown in pink.
CYP2B4, the open CYP3A4 form is likely to be catalytically active.
Similar to the crystal lattice of open CYP2B4, the open form of
CYP3A4 also displays a variety of arrangements including distal-
to-distal (not intercalated) and side-to-side. Thus, these open
forms may be versatile in the types of associations they can adopt.
The open conformation has also been implicated for a
R108H mutant of CYP2C9 through the use of size exclusion
chromatography, UV-visible spectrophotometry, pulsed electron
paramagnetic resonance, and molecular dynamics simulations
(Roberts et al., 2010). The mutant was isolated in a conformation
in which the substituted His in the B-C loop coordinated
intramolecularly with the heme group. Thus, this form is a
monomer, but the mobility of the B-C loop in coordinating
with the heme is similar to the conformational mobility needed
to form the open conformation of CYP2B4. Because this
conformation was ascertained by physical techniques other than
X-ray crystallography, the tendency of this form to associate in a
proximal-to-proximal orientation cannot be determined.
Any open form in which inter- or intramolecular
rearrangement blocks substrate access to the active site would be
inhibitory. Thus, it seems open conformations of P450s may in
general, be a means to limit the activities of the P450s by favoring
the formation of proximal-to-proximal arrangements that are
deficient in binding to CPR. Unfortunately, very few P450
crystal structures have been isolated in the open conformation to
confirm that this form consistently adopts these arrangements.
Thus, this hypothesis needs further testing. However, it should
be pointed out that the arrangement is observed in all of the
available open-form crystal structures.
It is clear that the crystal structure of CYP1A2 is unusual
in adopting a proximal-to-proximal arrangement in the closed
conformation. Furthermore, it can also be argued that CYP1A2
would be incapable of adopting the open conformation given its
narrow active site that is conducive for metabolism of planar,
aromatic substrates (Sansen et al., 2007). If the conformation
of CYP1A2 did open up, the P450 would be expected to
metabolize a wider range of substrates. Thus, the proximal-
to-proximal interaction may have an important regulatory role
in P450-mediated catalysis, and CYP1A2 may utilize its ability
to adopt this arrangement in the closed form to influence the
conformation and quaternary structure of interacting P450s.
CYP2C9 Interactions
Stimulation of CYP2C9-mediated activity through a mechanism
involving higher CPR binding affinity was also reported for
the interaction of the P450 with CYP2C19 (Hazai and Kupfer,
2005). An explanation for this effect was proposed through an
examination of CYP2C9 crystal structure in a subsequent study
(Hazai et al., 2005). At the time of this study, the number of
available crystal structures for mammalian P450s was limited, and
the functional effects of P450–P450 interactions were interpreted
solely by the potential effects on CPR binding as this was the only
identified mechanism.
To explain the activation of CYP2C9 metabolism by its
interaction with CYP2C19, the previous study examined a
side-to-proximal dimer (PDB: 1OG5; Figure 7) which has the
proximal face of one unit being occluded by the side of the protein
containing the C-terminal end of the I-helix and the J-helix. In
the previous study, it was postulated that the CYP2C9 dimer
would bind CPR with greater affinity than a CYP2C9 monomer
because the exposed J and K helices of the obstructed proximal
face would contribute to CPR binding by the exposed proximal
face of the self-interacting CYP2C9 unit. Although this is an
intriguing conclusion to be drawn from this crystal structure
arrangement, it must also be considered that this complex instead
represents an inhibitory, homomeric CYP2C9 complex because
FIGURE 7 | Crystal structure of side-to-proximal dimer of CYP2C9
bound to warfarin (PDB: 1OG5). The units of the dimer are oriented with the
N-terminal region (shown in blue) at the base of the dimers in a “membrane
plane” running perpendicular to the plane of the image. The heme groups are
shown as red spheres with α-helices drawn as cylindrical features. The F-G
helices region on the distal surfaces of the dimer are shown in yellow. Warfarin
molecules (pink) are bound in the active sites.
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one of the two proximal faces is sterically hindered in its ability
to bind CPR. Thus, at least one of the two CYP2C9 units in the
dimer would be catalytically limited. Furthermore, it is possible
that CPR binding to the “exposed” proximal side of the alternate
unit also would be limited because it is partially obstructed in the
crystal structure.
Because positional heterogeneity implies that any heteromeric
P450–P450 interaction stimulating a P450 catalytic activity
can also be interpreted as the homomeric interactions being
inhibitory, the side-to-proximal interaction of CYP2C9 may
instead be inhibitory and not one that is characterized by
increased CPR-binding affinity. As a result, the stimulation of
CYP2C9 through its interaction with CYP2C19 may be mediated
through a quaternary structure that fully exposes the CYP2C9
proximal face, possibly doubling the amount of catalytically
active CYP2C9 relative to what would be observed with the
homomeric CYP2C9 dimer (PDB: 1OG5). The CYP2C19 crystal
lattice (PDB:4GQS; Figure 8) shows one arrangement that would
be a credible membrane alignment in which the N-terminal ends
of a symmetrical dimer interact in a manner that would expose
the proximal faces at a rather flat angle to the membrane normal
with the distal faces buried below the membrane surface. In
conjunction with this arrangement, many hydrophobic residues
on the distal side project below what would be the membrane
surface in this orientation. Thus, the functional effects reported
for this interaction could be explained if a greater proportion
of CYP2C9 adopted the “CYP2C19-like” arrangement at the
expense of the side-to-proximal dimer associated with the
CYP2C9 crystal lattice, and more of the CYP2C19 adopted the
CYP2C9 homodimer arrangement.
FIGURE 8 | Crystal structure of side-to-side dimer of CYP2C19 bound
to (2-methyl-1-benzofuran-3-yl)-(4-hydroxy-3,5-dimethylphenyl)
methanon (PDB: 4GQS). This arrangement typifies the interactions that can
be observed in the CYP2C9 crystal lattice. The units of the dimer are oriented
with the N-terminal region at the base of the dimers in a “membrane plane”
running perpendicular to the plane of the image. The crystal is predominated
by many side-on interactions, many of which do not orient in a manner
consistent with being incorporated in a single membrane bilayer. The heme
groups are shown as red spheres with α-helices drawn as cylindrical features.
The molecules of (2-methyl-1-benzofuran-3-yl)-(4-hydroxy-3,
5-dimethylphenyl) methanon bound to the active site are shown in pink.
The distinction between a conformational mechanism and the
one involving a change in the arrangement of a P450 complex
that exposes the proximal face of the P450 is significant. In
the second case, the amount of a specific P450 participating in
the metabolism of a substrate would increase because a higher
proportion of the P450 would have the ability to interact with
CPR. It is important to note that this effect could mistakenly be
attributed to a change in the rate of a catalytic step of the reaction
cycle. To take the effects of the CYP2C9-CYP2C19 interaction
as an example (Hazai and Kupfer, 2005), stimulation of the
CYP2C9-mediated metabolism of methoxychlor was observed
in the presence of CYP2C19 when CPR was at a saturating
concentration. This would not happen if the change was caused
by a conformation-related increase in the binding affinity of
CPR and CYP2C9 because the CPR level was saturating both
in the presence and absence of CYP2C19. However, the effect
could be explained if the interaction of CYP2C9 with CYP2C19
causes more of the proximal face of CYP2C9 to be exposed
for binding to CPR. Thus, any P450–P450 interaction that has
been attributed to a change in the rate of a catalytic step, other
than substrate binding, may in fact be caused by this mechanism
instead. In other words, any apparent change in the kcat of a
reaction associated with a P450–P450 interaction could instead
be attributable to an alteration in the amount of available active
enzyme through a re-rearrangement within a P450 multimer that
exposes or hides more of the proximal face of the affected P450
(i.e., an effective increase it total active enzyme would present as
an increase in kcat).
Another important kinetic distinction in the formation of the
proximal-to-proximal dimer is that the P450 in this arrangement
would be effectively removed from the population of P450
capable of binding CPR. Thus, if there is a net exchange of
one P450 form for another in this arrangement, the effective
CPR:P450 ratio would increase for the P450 that is activated
through this mechanism. This would be another potential
mechanism for enzymatic stimulation in the mixed system.
P450–P450 Interactions That Influence
Substrate Binding
As reviewed previously (Reed and Backes, 2016), the interactions
of CYP2C9 with CYP2D6 (Subramanian et al., 2009) (and
possibly with CYP3A4) (Subramanian et al., 2010) and CYP2B4
with CYP2E1 (Kenaan et al., 2013) have been shown to
cause inhibition of CYP2C9 and CYP2B4, respectively, by
increasing the dissociation constants for substrate binding.
Changes in substrate binding could be plausibly explained
through P450–P450 interactions that involve the distal side of
the affected P450. A distal-to-distal P450 quaternary structure is
commonly observed in P450 crystal lattices. A membrane-bound
analog of this type of dimer is typified by the crystal structure
of CYP2C8 (Hu et al., 2010). In these types of dimers, the P450s
can assume either closed or open conformations around the
active site, and the F and G helices of the interacting P450s
form the dimerization interface. Interestingly, the dimerization
of CYP2C8 probably causes the F/G loops to be pulled out of
the membrane bilayer (Schoch et al., 2004; Ozalp et al., 2006).
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This effect in turn, would likely affect substrate binding to the
enzyme and would probably inhibit metabolism of hydrophobic
substrates that partition largely to the membrane. Perhaps, in its
interaction with CYP2C9, CYP2D6 may favor a rearrangement
of the CYP2C9 that obstructs its distal face and in turn,
causes its substrate to bind less tightly to its active site and
inhibits CYP2C9-mediated metabolism in the process. Similarly,
by consideration of positional heterogeneity as the primary
determinant of P450–P450 effects, it would be presumed that
CYP3A4 binds to the distal side of CYP2C9 to disrupt binding
of S-naproxen and S-flurbiprofen, and in a similar manner,
CYP2E1 (at high enzyme concentrations) distorts the distal side
of CYP2B4 and negatively influences binding of benzphetamine
to its active site (Kenaan et al., 2013).
A more recent study (Bostick et al., 2016) has reported that
the interaction of CYP2D6 and CYP2C9 resulted in stimulation
of the CYP2C9-mediated metabolism of S-flurbiprofen [the
same substrate in the study reporting inhibition of CYP2C9
(Subramanian et al., 2009)]. There were several distinctions in
the methods used in the two studies that could explain the
discrepancy in the findings. Most importantly, the reaction went
for 16 h in the later study, and it was reported that the rates were
not linear over this time period. Thus, “stimulation” could merely
reflect longer enzymatic stability when CYP2C9 was in the mixed
complex, and the earlier study probably describes the effects of
the CYP2C9-CYP2D6 interaction more accurately.
Putative Hexameric Quaternary
Structure of Membrane-Bound CYP2C9
In examining crystal lattices of purified P450s for the putative
hexameric aggregate that has been implicated by electron
microscopy (Tsuprun et al., 1986; Myasoedova and Tsuprun,
1993) and saturation transfer electron paramagnetic resonance
(Schwarz et al., 1982), an interesting arrangement can be
observed in the crystal lattice of CYP2C9 (PDB: 1OG5;
Figures 9A,B) in which a large-scale pattern that includes a
trimer of asymmetric dimers can be observed. The dimers
referred to are the side-to-proximal dimers described above.
The arrangement is intriguing in that it is consistent with
functional membrane binding and has similar features to the
hexameric structures of CYP1A2 (Myasoedova and Tsuprun,
1993) and CYP2B4 (Tsuprun et al., 1986) observed by electron
microscopy as it is comprised of two types of contacts between
the CYP2C9 units of the hexamer. In addition to the side-to-
proximal interaction, the three sets of dimers are joined together
with threefold symmetry along the distal faces and the side
between the proximal and distal faces that contains the regions
between the B/C helices and the H/I helices in addition to the
C-terminus of the enzyme. Future research should consider this
hexamer as a possible quaternary structure when metabolism by
CYP2C9 is assessed in the context of P450–P450 interactions.
DISCUSSION
Physical studies have convincingly shown that P450s have a
propensity to form complexes in membranes. Studies measuring
FIGURE 9 | Crystal lattice of side-to-proximal dimer of CYP2C9 (PDB:
1OG5) (shown in Figure 7) showing conceivable hexameric association
within a membrane. The crystal lattice of the side-to-proximal dimer shown
in Figure 7 was examined for higher ordered quaternary structure. (A) Shows
a trimeric association of the dimers in threefold symmetry formed from a side
abutting in an angle against a neighboring distal region of an adjacent
CYP2C9 unit. The N-terminal, membrane-binding region for each unit is at the
bottom of the hexamer in the plane of the page. (B) Shows the same hexamer
with the blue N-terminal ends arranged at the bottom of the hexamer in a
common plane that runs perpendicular to the plane of the image. The heme
groups are shown as red spheres with α-helices drawn as cylindrical features.
The F-G helices region on the distal faces of the hexamer units are shown in
yellow.
FRET/LRET and surface plasmon resonance now allow for
determinations of the dynamics of P450–P450 association.
Measurements indicate dissociation constants ranging from 1 to
50 nM (0.05–0.6 pmol/m2 for calculations based on the two-
dimensional lipid bilayer). Thus, P450s bind with affinities that
are higher than those measured for some signaling complexes
within the plasma membrane where the dissociation constants of
various Gα subunits for the Gβγ subunit, coupled to the N-formyl
peptide receptor, ranged from 1 to 3 µM (Bennett et al., 2001).
Studies with cross-linkers and those designed to monitor the
rotational mobility of P450s indicate the presence of dimeric
to hexameric (and larger?) P450 multimers in membranes with
some P450–P450 interactions being governed by electrostatic
forces possibly involving amine groups in the polar linker region
and/or the proximal faces of the enzymes. In natural membranes,
P450s form complexes of varying sizes with higher ordered
aggregates containing essentially rotationally immobilized P450
units.
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These P450–P450 interactions would not be of particular
interest if they did not impart functional changes that affect drug
metabolism. However, the P450 units in these multimers display
positional heterogeneity with respect to chemical/enzymatic
reduction, spin state, and access to substrate. The heterogeneity
of P450 multimers with respect to these properties is a testament
to the quasi-irreversible nature of P450–P450 associations and
is the underlying source of the functional effects of P450–P450
interactions with regards to drug metabolism.
An integral question concerning the functional effects of
P450–P450 interactions involves the physiologic rationale for
their existence. Given their important role in the elimination
of hydrophobic xenobiotics, it may seem counter-intuitive that
their activities could be selectively inhibited by oligomerization.
Enzymatic regulation through oligomerization also provides
a means for the P450 system to respond immediately to
the presence of a given substrate through quaternary re-
arrangements that “unmask” otherwise latent P450-mediated
activities. If this were not the case, the P450 system might be
ineffective at removing the compound until delayed induction
of the relevant P450s. In addition, the P450 catalytic cycle
depends on the activation of molecular oxygen through the
transfer of electrons to the heme group. This process can result
in uncoupling and the generation of destructive reactive oxygen
species. Thus, the regulation of P450-mediated activities through
oligomerization may provide a mechanism to limit deleterious
uncoupling reactions. This topic has been addressed more fully
in other reviews (Zangar et al., 2004; Davydov, 2011). It is also
possible that P450 oligomerization has a more complex role with
the expression of specific P450s serving to silence or enhance the
activities of P450s with which they tend to interact.
Despite the fact that general mechanisms involving altered
CPR and/or substrate binding have been identified for the
functional effects of P450–P450 interactions, the specific ways
that the interactions cause these changes have been difficult
to interpret. Typically, general explanations attribute the
phenomena to protein conformation changes. Undoubtedly,
undefined conformation changes are the underlying causes given
that the effects of P450–P450 interactions are substrate-specific.
For instance, all interactions involving CYP2E1 and CYP2B4 do
not cause activation of the former and inhibition of the latter
(Kelley et al., 2006). However, p-nitrophenol and benzphetamine
trigger specific conformation changes in CYP2E1 and CYP2B4,
respectively, that lead to those effects when the two P450s interact
(Kenaan et al., 2013).
While the underlying protein conformational changes that
affect oligomerization are important to elucidate, the actual
changes in oligomerization affecting positional heterogeneity
are possibly the ultimate source of functional changes. In
fact, it can be reasoned that certain arrangements of P450s
would have very predictable consequences on drug metabolism.
Thus, for this review, we have examined the crystal lattices of
several P450 structures to identify arrangements that may be
analogous to their organization in membranes, with the ultimate
objective of identifying potential changes in oligomerization that
would explain the alterations in function observed with specific
P450–P450 interactions.
To explain the role of oligomerization in affecting the
enzymatic function of drug-metabolizing P450s, it is proposed
that the degree and the variability of P450 oligomerization
represents a P450-specific equilibrium that is influenced by
the conformational state of the protein. The conformational
variability of most P450s (except CYP1A) is proposed to
be distinguished by the open and closed states represented
by CYP2B4 crystal structures (PDB: 1PO5 and PDB: 1SUO,
respectively), with ligand-free CYP2B4 existing in the membrane
in both states. In most cases, substrate binds to or triggers
formation of the closed state. The exception to this trend
would be cases such as that with CYP3A4 when large substrates
are bound to the active site which in itself induces the open
conformation of the enzyme.
The model maintains that each P450 displays a specific
tendency to distribute to different proportions of P450–P450
associations that can be categorized as distal-to-distal, proximal-
to-proximal, side-to-side, and side to either proximal or distal
faces. Thus, interactions between different P450s cause a
redistribution of each P450 to different proportions of each
arrangement which is influenced by the tendency of the binding
partner to adopt a specific arrangement. It is proposed that
a functional effect is associated with a P450–P450 interaction
when the interaction causes changes in the relative proportions
(as compared to the proportions observed in homomeric
reconstituted systems) of side-on; distal-to-distal; and proximal-
to-proximal P450 arrangements. More specifically, an interaction
with a P450 that favors distal-to-distal (e.g., CYP2D6, PDB:
2F9Q) or proximal-to-proximal (e.g., CYP1A2) arrangements
would be expected to result in inhibition of P450s that participate
in predominantly side-on interactions [e.g., CYP2B4 (Figure 4)
and CYP2C19 (Figure 8)]. In conjunction, this has been shown
to be the case for several P450–P450 interactions involving these
P450s (Hazai and Kupfer, 2005; Reed et al., 2010; Kenaan et al.,
2013).
This is not meant to imply that CYP2B4 and CYP2C19
only arrange in side-on interactions in the membrane. Clearly,
the functional heterogeneity of CYP2B4 has been demonstrated
(Davydov et al., 1985, 1995; Backes and Eyer, 1989) and may
represent a mixture of distal-to-distal (and possibly proximal-
to-proximal of the open form) in addition to the side-
on interactions. Conformational changes caused by substrate
binding would be predicted to alter the proportions of the
P450 in each characteristic state of oligomerization. Interestingly,
distal-to-proximal interactions were not observed in any of the
mammalian structures although they have been reported for
bacterial P450s (Ravichandran et al., 1993). This leads to the
possibility that the arrangement of P450 units in multimers
is not random. Thus, distal-to-distal and proximal-to-proximal
interactions may be specific mechanisms that have evolved to
regulate the activities of membrane-bound P450s.
For most P450s except CYP1A2, the open conformation of
P450 appears to be uniquely associated with both proximal-to-
proximal and the distal-to-distal dimeric interaction in which
the F-helix of one binding partner intercalates with the active
site of the interacting P450 (for simplicity, this will be referred
to as the intercalated open-form dimer). As described above,
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both of these open arrangements are inactive. CYP1A2 presents
an unusual situation for the drug-metabolizing P450s because
it is not thought to be able to adopt the open conformation.
However, unlike most of the drug-metabolizing P450s, CYP1A2
can adopt the proximal-to-proximal arrangement when it
is in the closed, substrate-binding conformation. For other
drug metabolizing P450s, the proximal-to-proximal interaction
has only been associated with crystal lattices of open form
P450s. Thus, rearrangement of CYP1A2 from its proximal-to-
proximal orientation to one associated with optimal catalytic
activity upon its interaction with another P450 would stimulate
CYP1A2 by increasing the total amount of “enzymatically active
CYP1A2” and also by increasing the effective CPR:CYP1A2
ratio. Conversely, the P450 interacting with CYP1A2 may be
inhibited because of the increased accessibility of CYP1A2 to
the limiting concentrations of CPR. Inhibition may also occur
if the affected P450 interacts as an open form in a proximal-to-
proximal manner with CYP1A2.
Distal-to-distal interactions commonly observed in many
P450 crystal structures in which the units of the P450 multimer
interact on the periphery of the distal regions of P450s in the
closed conformation are proposed to be impaired in substrate
binding. The analogous membrane-bound CYP2C8 dimer has
been proposed to be deficient in lipophilic substrate binding from
the membrane (Hu et al., 2010). Changes in the relative amounts
of this type of dimer may explain the functional interactions of
CYP2C9-CYP2D6 (Subramanian et al., 2009); CYP2C9-CYP3A4
(Subramanian et al., 2010); and possibly CYP2E1-CYP2B4 (when
a high concentration of CYP2E1 interacts with CYP2B4) (Kenaan
et al., 2013). CYP inhibition in these instances is caused by an
increase in the proportion of the affected P450 in the closed-
form, distal-to-distal arrangement and a corresponding decrease
in the proportion of enzyme involved in side-on interactions.
Homotropic and heterotropic cooperation in metabolism by
CYP3A4 have been related to this type of distal-to-distal dimer
(Davydov et al., 2013) indicating a limitation in the ability of
it to bind substrate until a putative access channel is opened
by effector binding to a peripheral site on the adjoining distal
regions of the dimer (Williams et al., 2004; Davydov et al.,
2015).
The proposed equilibria actually can explain all of the reported
functional effects of these interactions. For instance, changes
in the proportion of a P450 in a quasi-irreversible proximal-
to-proximal arrangement which are caused by interactions
with another P450 can explain the functional effects involving
modifications in CPR-binding capability. This also includes
mechanisms implicating a change in the apparent kcat as the
positional change of the affected P450 would present more or
less of the total enzyme population for interactions with CPR.
Note, the heterocomplex would need to be stable in the presence
of excess CPR like the CYP2C9-CYP2C19 complex in order for
rigorous kinetic analysis to detect an apparent change in kcat.
The purported effects for the proximal-to-proximal interaction
are believed to explain the reported functional interactions for
homomeric CYP1A2 (Reed et al., 2012) and for those between
CYP2C9-CYP2C19 (Hazai and Kupfer, 2005); CYP1A2-CYP2B4
(Backes et al., 1998); and CYP2E1-CYP2B4 (Kenaan et al., 2013).
In Fernando et al. (2008) three functional populations
were identified in the study of the positional heterogeneity of
P450–P450 complexes. One population responded to substrate
by shifting rapidly to the high spin form and subsequently being
reduced enzymatically to form the ferrous-CO complex. This
could represent closed-form, side-on P450–P450 interactions
fully capable of substrate and reductase binding (“HS+” in the
Fernando study).
Another population did not shift to high spin upon addition
of substrate and could not be reduced (“HS−” in previous
study). This characteristic could actually be representative of
the intercalated, open-formed P450 dimer and/or the open-form
proximal-to-proximal dimer. Clearly, the proximal-to-proximal
dimer would not be reducible given the fact that the dimer
is physically unable to interact with CPR. Furthermore, if the
dimerization limited conversion to the closed conformation, the
proximal-to-proximal CYP2B4 dimer also would be expected
to be intransigent to a substrate-induced spin state transition.
The “HS−” population also could represent the open-form,
intercalated dimer of CYP2B4 given the fact that it was thought to
be incapable of functionally interacting with CPR (note, a putative
opened-form dimer of CYP3A4 must be able to interact with CPR
in order to metabolize large substrates) and substrate would not
bind to the intercalated P450 dimer since the active site is blocked
by the F-helix of the binding partner. In support of the possibility
that the HS− population is represented (at least in part) by
the intercalated dimer, the biphasicity of the pre-steady state
reduction of CYP2B4 by CPR was explained by a model involving
a slow equilibrium between two conformations that bind to CPR,
but only one of which could be reduced (Backes and Eyer, 1989).
Thus, these two groups of CYP2B4 would be consistent with
P450 in side-on interactions and the open intercalated dimer of
CYP2B4. It is important to note that both types of open-form
dimerization may be a means to regulate P450 activities and may
be related by a dynamic equilibrium. However, because of the
constraints of the lipid membrane and the limitation imposed
by the P450s being tethered by the amino terminal tail, trimeric
quaternary structures comprised of both proximal-to-proximal
and distal-to-distal arrangements do not appear to be possible.
Thus, the two types of dimers are exclusive of one another.
The final population in the previous study consisted of low
spin CYP3A4 that was slowly converted to high spin prior to
enzymatic reduction (“HS0”). Substrate binding was proposed to
slowly shift the enzyme to the high spin/reducible form. This is
fully consistent with our predicted properties of the closed-form
distal-to-distal P450 complex as substrate binding is proposed to
be limited for this population which would in turn, cause a slower
spin state transition and subsequent reduction by the reductase.
The Fernando study indicated that ANF (the allosteric activator
of CYP3A4 that is believed to facilitate substrate binding by
interaction at the peripheral effector site of the dimer) was shown
to dramatically decrease the proportion of the HS0 population.
This would be expected if the peripheral binding by ANF
facilitates substrate access to the active sites of these closed form
CYP3A4 distal-to-distal dimers.
Although there has been significant progress on the topic of
the functional effects of P450–P450 interactions, there is still
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much more that is unknown than known about how these
interactions influence catalytic activities and drug metabolism
in vivo. For instance, of the roughly 40 possible binary P450–P450
interactions in liver that involve the major P450s in drug
metabolism and of the approximately 1500 drugs that have
been approved by the FDA (Kinch et al., 2014), only about 12
specific P450–P450 interactions related to the metabolism of
approximately 30 substrates (many of which are not even drugs)
have been studied (Reed and Backes, 2016). Another topic of
relevance that needs to be explored is the study of tissue-specific
P450–P450 interactions involving the unique assemblages of
P450s expressed in each tissue and the consequent functional
effects of these interactions.
In total, these findings suggest that heteromeric P450
association serves as a means to regulate specific P450-mediated
drug metabolism in vivo. Only rigorous comparative studies
will determine whether specific P450s preferentially interact. It
is possible that all P450s have similar tendencies to interact
with one another. If this is the case, identification of the P450s
involved in the metabolism of specific drugs (information that is
routinely obtained before phase I drug studies) will allow for the
determination of specific P450–P450 interactions that influence
metabolism of the given drug by the implicated P450. This
information will be invaluable in pharmaceutical risk assessment
and in pharmacokinetic evaluations of drug metabolism and
disposition.
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